drugset / Trial / NCT07386587
Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
Phase 3
Enrolling by invitation
60 enrolled
University of Child Health Sciences and Children's Hospital, Lahore
RandomizedParallel-groupOpen-labelTreatment
Summary
This open labelled randomized controlled trial will be carried out at the University of Child Health and the Children's Hospital, Lahore consisting of 6 months . In total 60 patients (30 in each group) fulfilling the inclusion criteria will be selected and enrolled in this study. Patients will be divided into two groups; Group A (Injection Etanercept+ Tab methotrexate) and Group B (Injection Etanercept+ Tab methotrexate). Data will be collected at baseline, 1,3 and 6 months. Data will be collected and recorded
Timeline
- Start
- 2026-01-27
- Primary completion
- 2026-07-27
- Completion
- 2026-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 0.8 mg/kg | Subcutaneous |